TY - JOUR AU - Strosberg, J. AU - El-Haddad, G. AU - Wolin, E. AU - Hendifar, A. AU - Yao, J. AU - Chasen, B. PY - 2017 DA - 2017// TI - Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1607427 DO - 10.1056/NEJMoa1607427 ID - Strosberg2017 ER - TY - JOUR AU - Bodei, L. AU - Kidd, M. AU - Paganelli, G. AU - Grana, C. M. AU - Drozdov, I. AU - Cremonesi, M. PY - 2015 DA - 2015// TI - Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-014-2893-5 DO - 10.1007/s00259-014-2893-5 ID - Bodei2015 ER - TY - JOUR AU - Ezziddin, S. AU - Lohmar, J. AU - Yong-Hing, C. J. AU - Sabet, A. AU - Ahmadzadehfar, H. AU - Kukuk, G. PY - 2012 DA - 2012// TI - Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate? JO - Clin Nucl Med VL - 37 UR - https://doi.org/10.1097/RLU.0b013e31823926e5 DO - 10.1097/RLU.0b013e31823926e5 ID - Ezziddin2012 ER - TY - STD TI - Bodei L, Kidd M, Modlin IM, Severi S, Drozdov I, Nicolini S, et al. Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors. Eur J Nucl Med Mol Imaging 2015. doi:https://doi.org/10.1007/s00259-015-3250-z. ID - ref4 ER - TY - JOUR AU - Claringbold, P. G. AU - Price, R. A. AU - Turner, J. H. PY - 2012 DA - 2012// TI - Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors JO - Cancer Biother Radiopharm VL - 27 UR - https://doi.org/10.1089/cbr.2012.1276 DO - 10.1089/cbr.2012.1276 ID - Claringbold2012 ER - TY - JOUR AU - Barber, T. W. AU - Hofman, M. S. AU - Thomson, B. N. AU - Hicks, R. J. PY - 2012 DA - 2012// TI - The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable JO - Eur J Surg Oncol VL - 38 UR - https://doi.org/10.1016/j.ejso.2011.08.129 DO - 10.1016/j.ejso.2011.08.129 ID - Barber2012 ER - TY - JOUR AU - Villard, L. AU - Romer, A. AU - Marincek, N. AU - Brunner, P. AU - Koller, M. T. AU - Schindler, C. PY - 2012 DA - 2012// TI - Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.37.2151 DO - 10.1200/JCO.2011.37.2151 ID - Villard2012 ER - TY - JOUR AU - Sandstrom, M. AU - Garske-Roman, U. AU - Granberg, D. AU - Johansson, S. AU - Widstrom, C. AU - Eriksson, B. PY - 2013 DA - 2013// TI - Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.107524 DO - 10.2967/jnumed.112.107524 ID - Sandstrom2013 ER - TY - JOUR AU - Ljungberg, M. AU - Frey, E. AU - Sjogreen, K. AU - Liu, X. AU - Dewaraja, Y. AU - Strand, S. E. PY - 2003 DA - 2003// TI - 3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations JO - Cancer Biother Radiopharm VL - 18 UR - https://doi.org/10.1089/108497803321269377 DO - 10.1089/108497803321269377 ID - Ljungberg2003 ER - TY - JOUR AU - Ljungberg, M. AU - Sjogreen, K. AU - Liu, X. AU - Frey, E. AU - Dewaraja, Y. AU - Strand, S. E. PY - 2002 DA - 2002// TI - A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using Monte Carlo simulation JO - J Nucl Med VL - 43 ID - Ljungberg2002 ER - TY - JOUR AU - Garkavij, M. AU - Nickel, M. AU - Sjogreen-Gleisner, K. AU - Ljungberg, M. AU - Ohlsson, T. AU - Wingardh, K. PY - 2010 DA - 2010// TI - 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: analysis of dosimetry with impact on future therapeutic strategy JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24796 DO - 10.1002/cncr.24796 ID - Garkavij2010 ER - TY - JOUR AU - Gustafsson, J. AU - Nilsson, P. AU - Gleisner, K. S. PY - 2013 DA - 2013// TI - On the biologically effective dose (BED)-using convolution for calculating the effects of repair: II. Numerical considerations JO - Phys Med Biol VL - 58 UR - https://doi.org/10.1088/0031-9155/58/5/1529 DO - 10.1088/0031-9155/58/5/1529 ID - Gustafsson2013 ER - TY - JOUR AU - Gleisner, K. S. AU - Brolin, G. AU - Sundlov, A. AU - Mjekiqi, E. AU - Ostlund, K. AU - Tennvall, J. PY - 2015 DA - 2015// TI - Long-term retention of 177Lu/177mLu-DOTATATE in patients investigated by gamma-spectrometry and gamma-camera imaging JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.155390 DO - 10.2967/jnumed.115.155390 ID - Gleisner2015 ER - TY - JOUR AU - Larsson, M. AU - Bernhardt, P. AU - Svensson, J. B. AU - Wangberg, B. AU - Ahlman, H. AU - Forssell-Aronsson, E. PY - 2012 DA - 2012// TI - Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy JO - EJNMMI Res VL - 2 UR - https://doi.org/10.1186/2191-219X-2-49 DO - 10.1186/2191-219X-2-49 ID - Larsson2012 ER - TY - JOUR AU - Svensson, J. AU - Molne, J. AU - Forssell-Aronsson, E. AU - Konijnenberg, M. AU - Bernhardt, P. PY - 2012 DA - 2012// TI - Nephrotoxicity profiles and threshold dose values for [177Lu]-DOTATATE in nude mice JO - Nucl Med Biol VL - 39 UR - https://doi.org/10.1016/j.nucmedbio.2012.02.003 DO - 10.1016/j.nucmedbio.2012.02.003 ID - Svensson2012 ER - TY - JOUR AU - Brolin, G. AU - Gustafsson, J. AU - Ljungberg, M. AU - Gleisner, K. S. PY - 2015 DA - 2015// TI - Pharmacokinetic digital phantoms for accuracy assessment of image-based dosimetry in (177)Lu-DOTATATE peptide receptor radionuclide therapy JO - Phys Med Biol VL - 60 UR - https://doi.org/10.1088/0031-9155/60/15/6131 DO - 10.1088/0031-9155/60/15/6131 ID - Brolin2015 ER - TY - JOUR AU - Gustafsson, J. AU - Brolin, G. AU - Cox, M. AU - Ljungberg, M. AU - Johansson, L. AU - Gleisner, K. S. PY - 2015 DA - 2015// TI - Uncertainty propagation for SPECT/CT-based renal dosimetry in (177)Lu peptide receptor radionuclide therapy JO - Phys Med Biol VL - 60 UR - https://doi.org/10.1088/0031-9155/60/21/8329 DO - 10.1088/0031-9155/60/21/8329 ID - Gustafsson2015 ER - TY - JOUR AU - Sundlov, A. AU - Sjogreen-Gleisner, K. AU - Svensson, J. AU - Ljungberg, M. AU - Olsson, T. AU - Bernhardt, P. PY - 2017 DA - 2017// TI - Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-017-3678-4 DO - 10.1007/s00259-017-3678-4 ID - Sundlov2017 ER - TY - STD TI - Hänscheid H, Lapa C, Buck AK, Lassmann M, Werner RA. Dose mapping after endoradiotherapy with 177Lu-DOTATATE/-TOC by one single measurement after four days. J Nucl Med 2017. doi:https://doi.org/10.2967/jnumed.117.193706. ID - ref19 ER - TY - BOOK PY - 2012 DA - 2012// TI - NU 1-2012 performance measurements of gamma cameras PB - NEMA Standards Publication CY - Rosslyn, Virginia ID - ref20 ER - TY - JOUR AU - Sjögreen Gleisner, K. AU - Ljungberg, M. PY - 2012 DA - 2012// TI - Patient-specific whole-body attenuation correction maps from a CT system for conjugate-view-based activity quantification: method development and evaluation JO - Cancer Biother Radiopharm VL - 27 UR - https://doi.org/10.1089/cbr.2011.1082 DO - 10.1089/cbr.2011.1082 ID - Sjögreen Gleisner2012 ER - TY - JOUR AU - Sjogreen, K. AU - Ljungberg, M. AU - Strand, S. E. PY - 2002 DA - 2002// TI - An activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 131I JO - J Nucl Med VL - 43 ID - Sjogreen2002 ER - TY - STD TI - Frey EC, Tsui BMW. A new method for modeling the spatially-variant, object-dependent scatter response function in SPECT. 1996 IEEE Nuclear Science Symposium. Annaheim: IEEE; 1996. p. 1082–6. https://doi.org/10.1109/NSSMIC.1996.587906. ID - ref23 ER - TY - JOUR AU - Ljungberg, M. AU - Sjogreen-Gleisner, K. PY - 2011 DA - 2011// TI - The accuracy of absorbed dose estimates in tumours determined by quantitative SPECT: a Monte Carlo study JO - Acta Oncol VL - 50 UR - https://doi.org/10.3109/0284186X.2011.584559 DO - 10.3109/0284186X.2011.584559 ID - Ljungberg2011 ER - TY - JOUR AU - Mortensen, N. AU - Morin, K. AU - Hermann, R. AU - Brolin, G. AU - Gustafsson, J. AU - Sundlöv, A. PY - 2014 DA - 2014// TI - Inter-operator variability in manual image segmentation and its impact on the renal absorbed dose and biologically effective dose in 177Lu-Dotatate therapy JO - Eur J Nucl Med Mol Imaging VL - 41 ID - Mortensen2014 ER - TY - JOUR AU - Delker, A. AU - Ilhan, H. AU - Zach, C. AU - Brosch, J. AU - Gildehaus, F. J. AU - Lehner, S. PY - 2015 DA - 2015// TI - The influence of early measurements onto the estimated kidney dose in [(177)Lu][DOTA(0),Tyr(3)]octreotate peptide receptor radiotherapy of neuroendocrine tumors JO - Mol Imaging Biol VL - 17 UR - https://doi.org/10.1007/s11307-015-0839-3 DO - 10.1007/s11307-015-0839-3 ID - Delker2015 ER - TY - JOUR AU - Thames, H. D. AU - Ang, K. K. AU - Stewart, F. A. AU - van der Schueren, E. PY - 1988 DA - 1988// TI - Does incomplete repair explain the apparent failure of the basic LQ model to predict spinal cord and kidney responses to low doses per fraction? JO - Int J Radiat Biol VL - 54 UR - https://doi.org/10.1080/09553008814551461 DO - 10.1080/09553008814551461 ID - Thames1988 ER - TY - JOUR AU - Stabin, M. G. AU - Sparks, R. B. AU - Crowe, E. PY - 2005 DA - 2005// TI - OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine JO - JNuclMed VL - 46 ID - Stabin2005 ER - TY - JOUR AU - Bland, J. M. AU - Altman, D. G. PY - 1986 DA - 1986// TI - Statistical methods for assessing agreement between two methods of clinical measurement JO - Lancet VL - 1 UR - https://doi.org/10.1016/S0140-6736(86)90837-8 DO - 10.1016/S0140-6736(86)90837-8 ID - Bland1986 ER - TY - CHAP AU - Searle, S. R. AU - Casella, G. AU - McCulloch, C. E. PY - 1992 DA - 1992// TI - The 1-way classification BT - Variance components PB - Wiley CY - Hoboken UR - https://doi.org/10.1002/9780470316856.ch3 DO - 10.1002/9780470316856.ch3 ID - Searle1992 ER - TY - STD TI - Evaluation of measurement data—guide to the expression of uncertainty in measurement. JCGM 100:2008. GUM 1995 with minor corrections. JCGM member organizations (BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP and OIML). 2008. ID - ref31 ER -